This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Rose Pharma LLC. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Olimpia Popko: Innovator in Glucagon-like Peptide Formulations
Introduction
Olimpia Popko is a notable inventor based in Munich, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of stable liquid formulations of glucagon-like peptide 1 (GLP-1) and its analogues. With a total of 2 patents to her name, her work is paving the way for advancements in treatment methodologies.
Latest Patents
Olimpia's latest patents focus on methods of treatment using stable liquid formulations of GLP-1 or its analogues. These formulations are designed to provide effective treatment for various disorders or conditions. The patents emphasize the stability and efficacy of these formulations, which are crucial for their application in medical treatments.
Career Highlights
Olimpia Popko is currently associated with Rose Pharma LLC, where she continues to innovate in the pharmaceutical sector. Her work is characterized by a commitment to improving patient outcomes through advanced therapeutic solutions.
Collaborations
Olimpia collaborates with talented professionals such as Andrea Hawe and Eva Keilhauer. These partnerships enhance her research and development efforts, contributing to the success of her projects.
Conclusion
Olimpia Popko's contributions to the field of glucagon-like peptide formulations highlight her role as a leading inventor in the pharmaceutical industry. Her innovative work continues to impact treatment methodologies positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile